| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $185.0B | $187.4B | $171.8B | $156.7B | $127.0B | $122.5B | $30.8B | $38.4B |
| Cost of Revenue | — | — | — | — | $100.5B | $97.5B | $110.7B | $120.7B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | $8.6B | $7.0B | $8.5B | $9.7B |
| Operating Income | $2.9B | $12.8B | $9.3B | $10.3B | $9.3B | $6.6B | $5.5B | $4.4B |
| Net Income | $2.7B | $6.0B | $10.1B | $9.9B | $10.0B | $6.4B | $-0.2B | $2.0B |
| EPS (Basic) | $3.33 | $6.45 | $7.35 | $6.17 | $6.78 | $4.36 | $4.62 | $5.61 |
| EPS (Diluted) | $3.27 | $6.37 | $7.32 | $6.13 | $6.70 | $4.33 | $4.57 | $5.53 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $281.3B | $279.8B | $273.1B | $264.0B | $244.7B | $235.2B | $228.0B | $227.3B |
| Current Assets | $108.8B | $108.5B | $101.6B | $100.5B | $82.1B | $80.9B | $75.0B | $75.3B |
| Cash & Equivalents | $20.9B | $19.9B | $18.9B | $19.2B | $20.1B | $20.0B | $19.1B | $20.8B |
| Total Liabilities | $218.1B | $214.2B | $204.8B | $191.8B | $178.9B | $185.5B | $182.1B | $184.6B |
| Current Liabilities | $93.3B | $96.3B | $94.4B | $91.2B | $74.4B | $79.9B | $84.9B | $82.2B |
| Stockholders' Equity | $61.1B | $63.1B | $64.3B | $67.8B | $59.7B | $45.0B | $41.8B | $38.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $26.9B | $20.1B | $20.9B | $16.0B | $15.2B | $16.7B | $15.0B | $15.3B |
| Investing Cash Flow | $-16.1B | $-20.5B | $-14.7B | $-17.9B | $-16.4B | $-21.8B | $-10.9B | $-20.8B |
| Capital Expenditures | $9.3B | $10.8B | $11.0B | $9.2B | $7.5B | $5.3B | $7.6B | $8.8B |
| Financing Cash Flow | $-9.6B | $1.9B | $-6.4B | $0.4B | $1.7B | $5.6B | $-4.7B | $11.5B |